We recently had the opportunity to get some feedback from outgoing Sahlgrenska Science board member, Stefan Bengtsson. Stefan is Principal and CEO of Chalmers University of Technology and was a board member of Sahlgrenska Science Park from 2015 to 2018. Read his interesting feedback below.
“I’ve had the privilege of participating in the board work within Sahlgrenska Science Park and thus closely following developments in the company for three years. There has been a fantastic development over the past three years, where the strategies have gradually been sharpened, and the response from the outside world has been both strong and positive.”
“There is enormous potential in the area between medicine and technology. For example, the development of digital technologies, such as artificial intelligence, brings new opportunities, and many believe that the effects will be extensive in most industries, including healthcare. At the same time, work in the area between medicine and technology is challenging as it requires multidisciplinary approaches. In addition, academia, industry and healthcare need to work closely together. I see Sahlgrenska Science Park as an incredibly important tool for success in the emerging field. Sahlgrenska Science Park is perfectly positioned to play an important role as a facilitator and enabler.”
“It will be exciting to see how Sahlgrenska Science Park evolves in the coming years as a collaboration arena! The prerequisites are now in place and, with the positive energy existing in Sahlgrenska Science Park, there is reason to be optimistic!”
Stefan Bengtsson is being replaced on the board by Ivan Mijakovic, Director of the Life Science Engineering Area of Advance at Chalmers University of Technology.
It’s also clear that Chalmers will open the Center for Artificial Intelligence in January 2019 – an initiative aimed at raising research, education and innovation within AI.